191588-94-0 Usage
Uses
Used in Acute Thrombotic Disorders:
Tenecteplase is used as a thrombolytic agent for the treatment of acute thrombotic disorders. It works by converting plasminogen to plasmin, which breaks down the fibrin in blood clots, thus restoring blood flow to the affected area. This application is particularly relevant in conditions such as acute myocardial infarction, ischemic stroke, and massive pulmonary embolism, where rapid clot dissolution is crucial for patient recovery and survival.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, tenecteplase is used as a key component in the development of drugs targeting thrombotic conditions. Its recombinant nature and specific modifications allow for a more controlled and targeted approach to clot dissolution, reducing the risk of bleeding complications associated with other thrombolytic agents. This makes tenecteplase a valuable asset in the development of novel therapeutic strategies for various thrombotic disorders.
Mechanism of action
Tenecteplase is composed of 527 amino acids with 17 disulfide bridges. It differs structurally from
anteplase by three point mutations. The mutations were bioengineered to occur at
amino acid 103, where threonine (T) is replaced by asparagine; at amino acid 117, where
asparagine (N) is replaced by glutamine; and at amino acids 296 to 299, where lysine (K)-histidinearginine-arginine are replaced with four alanines. Thus, the name TNK is derived from the
mutations. The replacement of these amino acids along with their attached carbohydrate side chains
results in a prolonged half-life (~17 minutes) and allows a single bolus application. These
point-mutation changes also change the binding of tenecteplase to plasminogen activator inhibitor-1
(PAI-1) by 80-fold, thus improving activity. A physiological enzyme, PAI-1 inhibits fibrinolysis.
Finally, tenecteplase shows a 15-fold higher fibrin specificity. The drug is still eliminated via hepatic
mechanisms.
Clinical Use
Thrombolytic:
Acute myocardial infarction
Drug interactions
Potentially hazardous interactions with other drugs
Drugs that affect coagulation or platelet function:
increased risk of bleeding.
Metabolism
Tenecteplase is cleared from circulation by binding to
specific receptors in the liver followed by catabolism to
small peptides.
Check Digit Verification of cas no
The CAS Registry Mumber 191588-94-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,5,8 and 8 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 191588-94:
(8*1)+(7*9)+(6*1)+(5*5)+(4*8)+(3*8)+(2*9)+(1*4)=180
180 % 10 = 0
So 191588-94-0 is a valid CAS Registry Number.